BJMO - volume 13, issue 6, october 2019
W. Lybaert MD, T. Vandamme MD, G. Boons , K. Vandenborne , L. De Backer , M. Peeters MD, PhD
MARCH 6-8TH, 2019, BARCELONA
Read moreBJMO - volume 13, issue 4, june 2019
W. Lybaert MD, H. Prenen MD, PhD, A. Demols MD, PhD, I. Dero MD
At the background of the Golden Gate Bridge with a view on the Pacific Ocean, the annual Gastrointestinal Cancers Symposium was held from 17–19 January 2019 in the Moscone Congress Center in San Francisco, California. The meeting further underlined the invasion of immunotherapy in the treatment landscape of gastrointestinal tumours, both in the upper and lower digestive tract. In addition to immunotherapy, lots of efforts were made in the molecular profiling of gastrointestinal cancers in every possible tumour location, which will hopefully fuel more biomarker-driven medicine in this setting in the near future. In this report, the most important headlines will be discussed, with comments on the clinical relevance of the different studies.
(BELG J MED ONCOL 2019;13(4):142–149)
Read moreBJMO - volume 13, issue 3, may 2019
T. Feys MBA, MSc, J. Beekwilder PhD
The 2019 annual American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium was held from February 14-16 in San Francisco. The Belgian Multidisciplinary Meeting on Urological Cancers (BMUC) organised a post-ASCO GU regional tour during which the highlights of the 2019 ASCO GU meeting were discussed. This tour featured four different meetings in four locations in Belgium: Namur, Ghent, Nivelles and Paal. This summary will specifically report on the meeting held in Ghent during which prof. dr Piet Ost (Ghent University Hospital) and prof. dr Sylvie Rottey (Ghent University Hospital) gave a summary of the most important advances in the treatment of prostate, bladder and renal cancer.
(BELG J MED ONCOL 2019;13(3):109–114)
Read moreBJMO - volume 13, issue 2, march 2019
H. Van Poppel MD, PhD
Marking its decade-long dedication to the goal of pursuing multidisciplinary collaboration, the 10th European Multidisciplinary Congress on Urological Cancers (EMUC18) examined the best practices, advances and future prospects in managing genitourinary malignancies. The congress also identified current dilemmas and addressed gaps in clinical practice.
(BELG J MED ONCOL 2019;13(2):63–65)
Read moreBJMO - volume 13, issue 2, march 2019
T. Feys MBA, MSc
From the 4–8th of December, the San Antonio Riverwalk again formed the background of the most important breast cancer congress in the world. This report will summarise eight top stories presented during the 2018 San Antonio Breast Cancer Symposium (SABCS). For a more complete overview of studies presented at the meeting, we refer to the congress website www.sabcs.org.
(BELG J MED ONCOL 2019;13(2):66–71)
Read moreBJMO - volume 12, issue 7, november 2018
H. Van Poppel MD, PhD
At the occasion of the Annual Congress of the European Association of Urology (EAU), a number of new trial protocols with new immuno-oncology drugs were presented for bladder and renal cancer next to the results of studies on adjuvant and neo-adjuvant chemotherapy for upper tract transitional cell carcinoma. In prostate cancer, the value of prostate-specific antigen screening and multiparametric MRI at first diagnosis was investigated, and the results of clinical trials with enzalutamide and apalutamide were reported.
(BELG J MED ONCOL 2018;12(7):339–341)
Read moreBJMO - volume 12, issue 5, september 2018
W. Lybaert MD, T. Vandamme MD, G. Boons , T. Rondou , M. Twickler , I. Dero MD, F. van Fraeyenhove MD, L. De Backer , D. Van Genechten , M. Peeters MD, PhD
March 7-9, 2018, Barcelona, Spain.
(BELG J MED ONCOL 2018:12(5):252–262)
Read more
Top
